YBX1 and systemic sclerosis: A review of the literature reveals that autoantibodies targeting YB-1 protein have been described in patients diagnosed with autoimmune diseases such as systemic sclerosis, primary biliary cholangitis autoimmune hepatitis (PBC-AIH) as well as autism spectrum disorders [15,16,17].